Of this subset, 645 RNAs were increased in platelets of MS patients as compared to HCs, including the RNAs EPSTI1 and IFI6, whereas RPS6KA3 had decreased levels in MS patients as compared to HCs (Table 2; Table S2). This evidence concerns the gene EPSTI1 and myeloid sarcoma.